Data Integrity & Compliance
Maintaining data integrity and compliance is fundamental to the credibility of clinical research. This session examines key principles and regulations governing data quality, including ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, Complete) standards, 21 CFR Part 11, and GxP guidelines. Attendees will learn how to design compliant workflows, conduct data audits, and implement role-based access controls to protect sensitive information. The session discusses common data integrity risks—such as transcription errors, unauthorized edits, and system malfunctions—and presents mitigation strategies through validation protocols and monitoring plans. Case studies from sponsor and CRO perspectives highlight real-world data integrity breaches and regulatory outcomes. By the end of the session, participants will understand how to build a culture of quality, foster accountability, and align operational practices with evolving global regulatory expectations.
Related Conference of Data Integrity & Compliance
30th International Conference on Neuropharmacology and Neurochemistry
Data Integrity & Compliance Conference Speakers
Recommended Sessions
- Adaptive Trial Models
- Advanced Data Analytics
- AI in Clinical Research
- AI-Powered Pharmacovigilance
- Blockchain Applications
- Clinical Supply Chain Innovation
- Data Integrity & Compliance
- Decentralized Trials
- Digital Therapeutics Trials
- Diversity in Enrollment
- eConsent & Retention Tools
- eSource & EDC Systems
- Global Regulatory Landscape
- Master Protocol Strategies
- Patient-Centric Designs
- Real-World Evidence Integration
- Risk-Based Monitoring
- Synthetic Control Arms
- Virtual Trial Platforms
- Wearables & Remote Monitoring
Related Journals
Are you interested in
- Artificial Intelligence in Neuropharmacological Drug Discovery - Neuropharmaceutics 2026 (Indonesia)
- Blood-Brain Barrier Pharmacology and Drug Delivery - Neuropharmaceutics 2026 (Indonesia)
- Brain-Computer Interfaces and Neurochemical Modulation - Neuropharmaceutics 2026 (Indonesia)
- Computational and Systems Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Digital Biomarkers and Neurochemical Monitoring Technologies - Neuropharmaceutics 2026 (Indonesia)
- Integrating Neurochemistry with Computational Brain Modeling - Neuropharmaceutics 2026 (Indonesia)
- Machine Learning Models in Neurochemical Data Analysis - Neuropharmaceutics 2026 (Indonesia)
- Molecular Mechanisms in Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Basis of Epilepsy and Anticonvulsant Pharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Basis of Mood Disorders and Emotional Regulation - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Big Data and Cloud-Based Pharmacology Platforms - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Biosensors and Real-Time Brain Monitoring - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Mechanisms in Neurodegenerative Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Signaling and Synaptic Transmission - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Addiction and Reward Pathways - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Neuroendocrine Regulation - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Psychiatric and Mood Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuroimaging Analytics and Computational Mapping of Brain Chemistry - Neuropharmaceutics 2026 (Indonesia)
- Neuroinflammation and Pharmacological Modulation - Neuropharmaceutics 2026 (Indonesia)
- Neuroinformatics and Computational Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacological Approaches to Pain and Analgesia - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacological Approaches to Pain Modulation and Analgesia - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Addiction and Substance Abuse - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Cognitive Function and Memory - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neurodegenerative Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neurodevelopmental and Autism Spectrum Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neuroplasticity and Neural Regeneration - Neuropharmaceutics 2026 (Indonesia)
- Neurotransmitter Receptors and Signal Transduction - Neuropharmaceutics 2026 (Indonesia)
- Precision Neuropharmacology through Artificial Intelligence and Genomic Profiling - Neuropharmaceutics 2026 (Indonesia)
- Virtual Drug Screening and Molecular Docking in Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
